Cargando…

Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis

Pseudomonas aeruginosa remains one of the major causes of healthcare-associated infection in Europe; in 2019, 12.5% of invasive isolates of P. aeruginosa in Spain presented combined resistance to ≥3 antimicrobial groups. The Spanish nationwide survey on P. aeruginosa antimicrobial resistance mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valero, Ana, Rodríguez-Gascón, Alicia, Isla, Arantxa, Barrasa, Helena, del Barrio-Tofiño, Ester, Oliver, Antonio, Canut, Andrés, Solinís, María Ángeles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620410/ https://www.ncbi.nlm.nih.gov/pubmed/34834314 http://dx.doi.org/10.3390/pharmaceutics13111899

Ejemplares similares

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine
por: Ibar-Bariain, Maitane, et al.
Publicado: (2019)

The Versatile Mutational Resistome of Pseudomonas aeruginosa
por: López-Causapé, Carla, et al.
Publicado: (2018)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
por: Alarcia-Lacalle, Ana, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2023)

Molecular Epidemiology, Antimicrobial Surveillance, and PK/PD Analysis to Guide the Treatment of Neisseria gonorrhoeae Infections
por: Alonso, Rodrigo, et al.
Publicado: (2021)

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
por: Bilbao-Meseguer, Idoia, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
por: Bilbao-Meseguer, Idoia, et al.
Publicado: (2021)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis
por: Herrera-Espejo, Soraya, et al.
Publicado: (2022)

PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Pseudomonas aeruginosa Lung Infection.
por: Tewes, Frederic, et al.
Publicado: (2023)

VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain
por: Viedma, Esther, et al.
Publicado: (2012)

Susceptibility Rates of Pseudomonas Aeruginosa Strains to Quinolones
por: Adhikari, Luna, et al.
Publicado: (2010)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020
por: García-Fernández, Sergio, et al.
Publicado: (2023)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile
por: Pragasam, Agila K., et al.
Publicado: (2016)

Distinctive Regulation of Carbapenem Susceptibility in Pseudomonas aeruginosa by Hfq
por: Sonnleitner, Elisabeth, et al.
Publicado: (2020)

Negative Impact of Citral on Susceptibility of Pseudomonas aeruginosa to Antibiotics
por: Tetard, Alexandre, et al.
Publicado: (2021)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
por: Xiao, Xia, et al.
Publicado: (2021)

Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain
por: Gomila, Margarita, et al.
Publicado: (2013)

Draft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain
por: Viedma, Esther, et al.
Publicado: (2014)

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
por: Zhou, Yu-Feng, et al.
Publicado: (2020)

Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
por: Soraluce, Amaia, et al.
Publicado: (2020)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

Decreased Antibiotic Susceptibility in Pseudomonas aeruginosa Surviving UV Irradition
por: Li, Hai-bei, et al.
Publicado: (2021)

Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Pseudomonas aeruginosa–induced nociceptor activation increases susceptibility to infection
por: Lin, Tiffany, et al.
Publicado: (2021)

The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa
por: Erdmann, Mareike B., et al.
Publicado: (2023)

PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK‐PD modeling from nonclinical to clinical development
por: Oggianu, Laura, et al.
Publicado: (2023)

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2014)

The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum
por: Zhang, Nan, et al.
Publicado: (2016)

Draft Genome Sequence of Petroleum Hydrocarbon-Degrading Pseudomonas aeruginosa Strain PK6, Isolated from the Saurashtra Region of Gujarat, India
por: Patel, P. A., et al.
Publicado: (2014)

Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats
por: Fernández-Varón, Emilio, et al.
Publicado: (2016)

Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection
por: Wheatley, Rachel, et al.
Publicado: (2021)

The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
por: Essoh, Christiane, et al.
Publicado: (2013)

Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria
por: Meradji, Samah, et al.
Publicado: (2015)

O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins
por: Ghequire, Maarten G K, et al.
Publicado: (2014)

Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of Pseudomonas aeruginosa
por: Liew, Siew Mun, et al.
Publicado: (2019)

In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics
por: Pan, Xiaolei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5tmautp79rcmhiuneeq8de0cku